 NanoViricides (NYSE: NNVC) is a clinical-stage biotech positioned to redefine antiviral therapy with its lead drug NV-387, a broad-spectrum, dual-action antiviral that not only destroys viruses before they infect cells but also protects critical organs like the lungs from immune-mediated damage. With resurgent measles outbreaks across the U.S., NV-387 has already demonstrated 130% increased survival and lung protection in humanized animal models, is safe and well-tolerated in Phase I trials, and is available as patient-friendly oral gummies. The drug's unique "Re-Infection Inhibition" nanotechnology makes it highly selective yet broadly effective, targeting measles, respiratory viruses, COVID-19, RSV, influenza, H5N1 bird flu, MPox, and smallpox, positioning NNVC as a versatile antiviral powerhouse ready to address multi-billion-dollar global markets. NNVC is executing a dual-track, rapid clinical development strategy to accelerate NV-387 toward broad use. Track 1 focuses on a Phase II trial against MPox in Congo, already ethically approved, with potential U.S. biodefense funding from BARDA. Track 2 targets respiratory viruses through an adaptive "basket-type" Phase II trial in India, including influenza, RSV, and coronaviruses, potentially starting in Winter 2026 and leading to focused U.S. trials by 2027. With strong clinical data, broad-spectrum applications, and multi-billion-dollar market potential, NV-387 is poised to become the go-to antiviral solution for urgent outbreaks and epidemic preparedness. Investors seeking the next biotech breakout of 2026 should watch NNVC closely. Today's editorial pick for you 2 Retail Stocks to Buy and 2 to Avoid Before EarningsPosted On Nov 14, 2025 by Chris Markoch  Many of the largest retail stocks are getting ready to report earnings the week of November 17. As I write this, we're about two weeks away from the official start of the holiday shopping season. Investors will be waiting to hear if retailers believe this will be a Black Friday or a Black-and-Blue Friday. Table of ContentsIn the prior earnings season, many retailers sounded the alarm on what's being called a "K-shaped" economy. This is a visual representation of the growing disparity between the highest-earning households, which are spending and expanding their wealth, and the lowest-income households, which are struggling to pay their day-to-day bills. Many retailers have said that low-income consumers have been under pressure for several quarters. However, they also say that the higher-income consumers continue to spend, relatively unabated. There's no reason to believe that things will be any different this earnings season. In much the same way, you can group retail stocks into the have's and the have not's. But in this case, you may not want to buy stocks that are on sale. Why Walmart Looks Like a Buy Heading into the HolidaysWhen the going gets tough, Walmart Inc. (NYSE: WMT) proves why it's the most reliable name among retail stocks. The company's recent updates show traffic is rising among higher-income households who are trading down for essentials and value. That shift is offsetting weaker sales among lower-income customers who are sticking to essentials. Walmart's e-commerce and membership service, Walmart+, is also a bright spot. In fact, it's helping Walmart close the gap with Amazon in omnichannel retail. Its grocery dominance provides steady cash flow, while digital advertising is becoming an underappreciated growth driver. What could change my mind? If inflation eases more quickly than expected, lower-priced retailers could see less trade-down activity. Walmart's valuation is also near its historical high, which could limit short-term upside if earnings disappoint. However, in a mixed economy, Walmart's scale and pricing power still make it one of the few dependable buys in retail. Why TJX Companies Belongs on Your Buy ListTJX Companies Inc. (NYSE: TJX), the parent company of T.J. Maxx, Marshalls, and HomeGoods, continues to thrive on its "treasure hunt" model, which keeps customers coming back even when budgets are tight. In a K-shaped economy, off-price retailing remains a sweet spot—appealing to value-driven consumers and offering brand-name goods at steep discounts. The company's efficient supply chain and ability to source excess inventory give it an edge that's hard to replicate. TJX has also shown strong margin discipline and consistent same-store sales growth, even as competitors struggle with overstocked shelves. What could change my mind? If consumer sentiment erodes further, discretionary categories like apparel and home décor could weaken. Supply chain normalization might also reduce the availability of excess inventory that fuels TJX's appeal. Still, its loyal customer base and proven model make TJX one of the few retail stocks that perform well in both good and bad times.  Why Target Still Looks Like a Stock to FadeTarget Corp. (NYSE: TGT) remains in a difficult transition. The retailer is trying to reposition itself after misjudging consumer demand in 2023 and facing inventory and traffic challenges throughout 2024. Management has shifted focus toward essentials, affordability, and smaller-store formats, but the company's unique selling proposition has become less clear. Once positioned as the upscale discount chain, Target continues to face pricing pressure from Walmart and style pressure from specialty retailers. Meanwhile, weak discretionary spending and theft issues continue to weigh on margins and same-store sales. What could change my mind? If Target delivers a holiday quarter showing renewed traffic and margin recovery, investor sentiment could turn. New store initiatives and digital growth could eventually gain traction. However, until the company proves it can stabilize earnings and differentiate again, Target is on the naughty list of retail stocks. Why Lululemon May Not Be Ready for a Rebound YetLululemon Athletica Inc. (NASDAQ: LULU) remains a premium brand in the athleisure category, but competition is catching up fast. Even among higher-income consumers, there are signs of fatigue as rivals like Alo, Vuori, and Nike expand their offerings. The stock has been trending lower in 2025 as investors question whether growth in men's apparel and international markets can offset slowing North American sales. Margins remain strong, but valuation is still rich for a company showing moderating growth. Lululemon needs a strong holiday season to prove its premium positioning among retail stocks still resonates. What could change my mind? If Lululemon posts a surprise beat on revenue or gross margin—driven by international strength or a new product cycle—it could mark the start of a turnaround. For now, however, the risk-reward balance skews negative as the brand battles saturation in a crowded category. This message is a PAID ADVERTISEMENT for NanoViricides, Inc (NYSE: NNVC) from Interactive Offers. StockEarnings, Inc. has received a fixed fee of $7000 from Interactive Offers for multiple Dedicated Email Sends, Newsletter Sponsorships and SMS Sends between Nov 14, 2025 and Nov 20, 2025. Other than the compensation received for this advertisement sent to subscribers, StockEarnings and its principals are not affiliated with either NanoViricides, Inc (NYSE: NNVC) or Interactive Offers. StockEarnings and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither StockEarnings nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from StockEarnings to buy or sell any security. StockEarnings has not evaluated the accuracy of any claims made in this advertisement. StockEarnings recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding NanoViricides, Inc (NYSE: NNVC) on equiscreen website for additional information about the relationship between Interactive Offers and NanoViricides, Inc (NYSE: NNVC). StockEarnings, Inc |
